Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2025

Dec 2, 2025

33625_dirs_2025-12-02_2f480140-f328-4af3-91fb-cba278b875c7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2025-12-01

Reporting Person: Ramade Gregoire (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-01 Common Stock M 31566 Acquired 50189 Direct
2025-12-01 Common Stock F 12943 $6.95 Disposed 37246 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-01 Restricted Stock Unit $ M 31566 Acquired Common Stock (31566) Direct

Footnotes

F1: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2025.

F2: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F3: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.